During the past decade, Regional Government Institution Kipetsk Regional Psychoneurology Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 5 clinical trials were completed, i.e. on average, 500% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Regional Government Institution Kipetsk Regional Psychoneurology Hospital" are "Schizophrenia" (5 trials), "Bipolar Disorder" (1 trials) and "Depressive Disorder, Major" (1 trials). Many other conditions were trialed in "Regional Government Institution Kipetsk Regional Psychoneurology Hospital" in a lesser frequency.

Most popular intervention types in "Regional Government Institution Kipetsk Regional Psychoneurology Hospital" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Lurasidone" (4 trials), "Lurasidone 40 mg" (1 trials), "Lurasidone 80 mg" (1 trials), "Lurasidone 80 mg once daily initially rerandomized either to 80 mg or 160 mg at week 2" (1 trials) and "Matching Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Regional Government Institution Kipetsk Regional Psychoneurology Hospital" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Regional Government Institution Kipetsk Regional Psychoneurology Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Regional Government Institution Kipetsk Regional Psychoneurology Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Regional Government Institution Kipetsk Regional Psychoneurology Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".